A Case of Primary Resistance to Geﬁtinib due to Novel Deletion-Insertion Mutation of EGFR Exon 19 in NSCLC

J Thorac Oncol. 2019 Jun;14(6):e117-e119. doi: 10.1016/j.jtho.2019.01.033.

Authors

Peiyi Xia¹, Enjie Liu¹, Pan Li¹, Wencai Li¹, Guozhong Jiang²

Affiliations

¹ Department of Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.
² Department of Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China. Electronic address: guozhongjiang@zzu.edu.cn.

PMID: 31122561
DOI: 10.1016/j.jtho.2019.01.033

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / pathology
ErbB Receptors / genetics*
Exons / genetics*
Female
Gefitinib / pharmacology
Gefitinib / therapeutic use*
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Middle Aged
Mutation

Substances

ErbB Receptors
Gefitinib